Delcath Systems (DCTH +5.9%) is trading higher today following its announcement over the weekend...

|About: Delcath Systems, Inc. (DCTH)|By:, SA News Editor

Delcath Systems (DCTH +5.9%) is trading higher today following its announcement over the weekend that data from a Phase 3 trial of its chemosaturation system showed extended survival rates for patients with melanoma metastases in the liver. The company also says that separate data from a Phase 2 tests of the same system in a different application showed positive results as well.